Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;27(1):65-71.
doi: 10.1007/s11095-009-0007-z. Epub 2009 Nov 13.

Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates

Steven A Jacobs  1 , Sheng-Jiun Wu, Yiqing Feng, Deidra Bethea, Karyn T O'Neil
Affiliations

Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates

Steven A Jacobs et al. Pharm Res. 2010 Jan.

Abstract

Purpose: To develop a high-throughput cross-interaction chromatography screening method to rapidly identify antibody candidates with poor solubility using microgram quantities of purified material.

Methods: A specific recombinant antibody or bulk polyclonal IgG purified from human serum was chemically coupled to an NHS-activated chromatography resin. The retention times of numerous monoclonal antibodies were determined on this resin using an HPLC and compared to the solubility of each antibody estimated by ultrafiltration.

Results: Retention times of the antibodies tested were found to be inversely related to solubility, with antibodies prone to precipitate at low concentrations in PBS being retained longer on the columns with broader peaks. The technique was successfully used to screen microgram quantities of a panel of therapeutic antibodies to identify candidates with low solubility in PBS.

Conclusions: The cross-interaction chromatography methods described can be used to screen large panels of recombinant antibodies in order to discover those with low solubility. Addition of this tool to the array of tools available for characterization of affinity and activity of antibody therapeutic candidates will improve selection of candidates with biophysical properties favorable to development of high concentration antibody formulations.

PubMed Disclaimer

References

    1. Pharm Res. 2003 Sep;20(9):1325-36 - PubMed
    1. Protein Sci. 2004 May;13(5):1379-90 - PubMed
    1. Biologicals. 2006 Mar;34(1):5-14 - PubMed
    1. Nat Rev Drug Discov. 2004 May;3(5):383-4 - PubMed
    1. Genome Biol. 2007;8(11):R254 - PubMed

MeSH terms

Substances

LinkOut - more resources